Predicting GLP-1 Discontinuation From Pharmacy Claims
Published: | Updated:
|Articles|October 1, 1998
Supplements and Featured Publications
- The Treatment of Migraine: A Managed Care Perspective
- Volume 4
- Issue 10 Suppl
Etiology and Treatment Options for Migraine Management
Author(s)James U. Adelman, MD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
Introductionalmost 28 years ago
Current Treatment Strategies for Migraine Disorderalmost 28 years ago
The Economic Burden of Migraine: The Role of the Triptansalmost 28 years ago
Triptan Use and the Economic Impact of Migrainealmost 28 years ago
Management of Migraine: Opportunity or Bottomless Pit?almost 28 years ago
CME Quizalmost 28 years ago
Selected Abstractsalmost 28 years ago
BibliographyAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5